Skip to Content

The recent announcement by 23andMe, stating it now has FDA authorization to report on three specific BRCA1 and BRCA2 breast cancer gene mutations associated with breast, ovarian and prostate cancer via direct-to-consumer (DTC) testing, stirred up debate. Since reading about this announcement, I’ve been mulling over my thoughts on it. 

Read More about FDA Will Allow 23andMe to Offer DTC Test for Three BRCA Gene Mutations – Good or Bad Idea?

As we wrap up another Lymphedema Awareness month, I’m sharing some helpful resources about lymphedema, so they are more easily accessible, all in one place. In other words, I’m organizing. Yikes! (As some of you know, organization is not my strong suit. Trust me, it’s not.) Feel free to share your favorite LE resources with …

Read More about My Lymphedema Resource Round-Up

I am pleased to tell you, my dear readers, about the new book, Navigating the C: A Nurse Charts the Course for Cancer Survivorship Care, by my online friend, Alene Nitzky, Ph.D., RN, OCN. Blue Bayou Press LCC, 2018. 121 pages, plus a 66 page Appendix. I’ve been a fan of Alene Nitzky’s work for a …

Read More about “Navigating the C: A Nurse Charts the Course for Cancer Survivorship” by Alene Nitzky – A Review & Giveaway!